Sequent Scientific Limited

NSEI:SEQUENT Stock Report

Market Cap: ₹50.9b

Sequent Scientific Balance Sheet Health

Financial Health criteria checks 2/6

Sequent Scientific has a total shareholder equity of ₹7.4B and total debt of ₹4.5B, which brings its debt-to-equity ratio to 60.9%. Its total assets and total liabilities are ₹15.6B and ₹8.2B respectively. Sequent Scientific's EBIT is ₹867.4M making its interest coverage ratio 1.6. It has cash and short-term investments of ₹742.6M.

Key information

60.9%

Debt to equity ratio

₹4.52b

Debt

Interest coverage ratio1.6x
Cash₹742.60m
Equity₹7.42b
Total liabilities₹8.20b
Total assets₹15.62b

Recent financial health updates

Recent updates

We Think Sequent Scientific (NSE:SEQUENT) Is Taking Some Risk With Its Debt

Sep 27
We Think Sequent Scientific (NSE:SEQUENT) Is Taking Some Risk With Its Debt

What Sequent Scientific Limited's (NSE:SEQUENT) 32% Share Price Gain Is Not Telling You

Sep 05
What Sequent Scientific Limited's (NSE:SEQUENT) 32% Share Price Gain Is Not Telling You

Revenues Not Telling The Story For Sequent Scientific Limited (NSE:SEQUENT)

Apr 05
Revenues Not Telling The Story For Sequent Scientific Limited (NSE:SEQUENT)

Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet

Mar 10
Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet

Is Sequent Scientific's (NSE:SEQUENT) 177% Share Price Increase Well Justified?

Jan 31
Is Sequent Scientific's (NSE:SEQUENT) 177% Share Price Increase Well Justified?

How Much Did Sequent Scientific's (NSE:SEQUENT) CEO Pocket Last Year?

Jan 17
How Much Did Sequent Scientific's (NSE:SEQUENT) CEO Pocket Last Year?

Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?

Jan 05
Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?

What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?

Dec 24
What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?

Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?

Dec 12
Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?

Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly

Nov 22
Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly

Estimating The Intrinsic Value Of Sequent Scientific Limited (NSE:SEQUENT)

Nov 10
Estimating The Intrinsic Value Of Sequent Scientific Limited (NSE:SEQUENT)

The Sequent Scientific (NSE:SEQUENT) Share Price Is Up 102% And Shareholders Are Boasting About It

Oct 20
The Sequent Scientific (NSE:SEQUENT) Share Price Is Up 102% And Shareholders Are Boasting About It

How Does Sequent Scientific's (NSE:SEQUENT) CEO Pay Compare With Company Performance?

Oct 05
How Does Sequent Scientific's (NSE:SEQUENT) CEO Pay Compare With Company Performance?

Financial Position Analysis

Short Term Liabilities: SEQUENT's short term assets (₹8.3B) exceed its short term liabilities (₹4.9B).

Long Term Liabilities: SEQUENT's short term assets (₹8.3B) exceed its long term liabilities (₹3.3B).


Debt to Equity History and Analysis

Debt Level: SEQUENT's net debt to equity ratio (50.9%) is considered high.

Reducing Debt: SEQUENT's debt to equity ratio has increased from 43.1% to 60.9% over the past 5 years.

Debt Coverage: SEQUENT's debt is not well covered by operating cash flow (4.6%).

Interest Coverage: SEQUENT's interest payments on its debt are not well covered by EBIT (1.6x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 06:33
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sequent Scientific Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nikhil ShettyBP Wealth Management Private Limited
null nullIIFL Wealth Management Ltd.